Your browser doesn't support javascript.
loading
BAP1 Tumour Predisposition Syndrome Due to Whole BAP1 Gene Deletion.
Pandithan, Dinusha; Klebe, Sonja; McKavanagh, Grace; Rawlings, Lesley; Yu, Sui; Nicholl, Jillian; Poplawski, Nicola.
Afiliação
  • Pandithan D; Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Klebe S; Anatomical Pathology, SA Pathology and Flinders University, Flinders Medical Centre Site, Bedford Park, South Australia, Australia.
  • McKavanagh G; Molecular Pathology, Mater Hospital Brisbane, South Brisbane, Australia.
  • Rawlings L; Genetics and Molecular Pathology, SA Pathology, Adelaide Site, South Australia, Australia.
  • Yu S; Genetics and Molecular Pathology, SA Pathology, Adelaide Site, South Australia, Australia.
  • Nicholl J; Genetics and Molecular Pathology, SA Pathology, Adelaide Site, South Australia, Australia.
  • Poplawski N; Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Case Rep Genet ; 2022: 5503505, 2022.
Article em En | MEDLINE | ID: mdl-36148247
ABSTRACT
BRCA-1-associated protein-1 (BAP1) tumour predisposition syndrome (BAP1-TPDS) is a dominant hereditary cancer syndrome. The full spectrum of associated malignancies is yet to be fully characterised. We detail the phenotypic features of the first reported family with a whole BAP1 gene deletion. This report also adds to the emerging evidence that the rhabdoid subtype of meningioma is a part of the clinical spectrum of this tumour predisposition syndrome.

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Case Rep Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Case Rep Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália